NCT06772987View on ClinicalTrials.gov

NQ TMS for MDD Therapy Using 1 Day x 3 Sessions Protocol for Adult Patient

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 16, 2025

Primary Completion Date

May 6, 2025

Study Completion Date

May 6, 2025

Conditions
Major Depressive Disorder (MDD)
Interventions
DEVICE

Accelerated rTMS treatment

1 Day x 3 Sessions of 19-minutes rTMS treatment, with 60 minutes rest between sessions.

Trial Locations (1)

95124

LGTC Group, San Jose

Sponsors

Lead Sponsor

NeuroQore Inc.
All Listed Sponsors
collaborator

Makromed Inc.

UNKNOWN

lead

NeuroQore Inc.

INDUSTRY

NCT06772987 - NQ TMS for MDD Therapy Using 1 Day x 3 Sessions Protocol for Adult Patient | Biotech Hunter | Biotech Hunter